AGP Executive Report
Last update: 2 hours agoDEA Rescheduling Hearing: The federal government kicked off marijuana rescheduling arguments, pitching cannabis as having accepted medical value and lower abuse/overdose risk than opioids and alcohol, with the process running through mid-July. CBD Consumer Watch: CBDWatchlist.com launched a 2026 CBD Gummies and CBD Oil Transparency Review Initiative to help shoppers compare labeling, lab tests, and refund/shipping terms. Jail Safety Probe: A South Carolina sheriff says detention-center cases were withheld, including a death linked to synthetic cannabinoids (K2/Spice), leading to the arrest of the compliance director. Hemp Product Pushback: A restaurant association urged Congress to rethink a forthcoming hemp-products approach, asking for a delay. Gun Policy Spillover: The U.S. Supreme Court agreed to hear challenges to assault-style rifle bans, while also turning away a separate firearms age-restriction case—showing how major court fights keep reshaping drug-adjacent policy debates. Local CBD/Weed Enforcement: Police reports across the week included marijuana-linked arrests and seizures, from traffic stops to suspected supply cases.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
